Faculty of medicine
Sohag, 82425, Egypt
NCT Number: NCT05691335
comparison between standard cross-linking protocol and accelerated and transepithelial cross-linking
Looking for future studies?
Notify Me12 year–18 year
All sexes
Interventional
Not applicable
Sohag, 82425, Egypt
comparison between standard cross-linking protocol and accelerated and transepithelial cross-linking for treatment of documented pediatric keratoconus progression. The study patients are divided into 3 groups. Group A patient treated with standard cross-linking. Group B patients treated with accelerated cross-linking. Group C patients treated with transepithelial cross-linking.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Epithelium-off CXL performed by removal of corneal epithelium, instillation of riboflavin onto the cornea followed by UVA corneal irradiation for 30 minutes.
Epithelium-off CXL performed by removal of corneal epithelium, instillation of riboflavin onto the cornea followed by UVA corneal irradiation for 5 minutes.
Epithelium-on CXL performed by instillation of riboflavin onto the cornea followed by UVA corneal irradiation for 5 minutes.
Time frame: 36 months
measured in logarithm of minimal angle of resolution (logMAR)
Time frame: 36 months
measured in logarithm of minimal angle of resolution (logMAR)
Time frame: 36 months
measured in diopters (D)
Time frame: 36 months
measured in diopters (D)
Time frame: 36 months
measured in diopters (D)
Sohag University
Other
Analysis of the Outcomes of Three Different Cross-linking Protocols for Treatment of Pediatric Keratoconus
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06859398
Corneal Diseases, Corneal Ectasia
Edegem, Belgium
View Trial DetailsNCT06347900
Corneal Ectasia
Sohag, Egypt
View Trial DetailsNCT04667572
Corneal Degeneration, Corneal Diseases
Dallas, Texas, United States
View Trial DetailsNCT06348368
Corneal Ectasia
Sohag, Egypt
View Trial Details